| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | SEA | 3.45e-06 | 22 | 90 | 4 | PF01390 | |
| Domain | SEA | 4.16e-06 | 23 | 90 | 4 | PS50024 | |
| Domain | SEA_dom | 4.16e-06 | 23 | 90 | 4 | IPR000082 | |
| Domain | SEA | 3.79e-05 | 14 | 90 | 3 | SM00200 | |
| Domain | HIN_200 | 1.37e-04 | 4 | 90 | 2 | PS50834 | |
| Domain | HIN | 1.37e-04 | 4 | 90 | 2 | PF02760 | |
| Domain | HIN200/IF120x | 1.37e-04 | 4 | 90 | 2 | IPR004021 | |
| Domain | U2AF_small | 2.27e-04 | 5 | 90 | 2 | IPR009145 | |
| Domain | ZU5 | 8.09e-04 | 9 | 90 | 2 | SM00218 | |
| Domain | ZU5 | 1.01e-03 | 10 | 90 | 2 | PS51145 | |
| Domain | BAH | 1.23e-03 | 11 | 90 | 2 | SM00439 | |
| Domain | BAH | 1.23e-03 | 11 | 90 | 2 | PF01426 | |
| Domain | BAH | 1.23e-03 | 11 | 90 | 2 | PS51038 | |
| Domain | BAH_dom | 1.23e-03 | 11 | 90 | 2 | IPR001025 | |
| Domain | ZU5 | 1.47e-03 | 12 | 90 | 2 | PF00791 | |
| Domain | ZU5_dom | 1.47e-03 | 12 | 90 | 2 | IPR000906 | |
| Domain | - | 2.31e-03 | 15 | 90 | 2 | 3.30.70.960 | |
| Domain | DAPIN | 4.98e-03 | 22 | 90 | 2 | PS50824 | |
| Domain | PYRIN | 4.98e-03 | 22 | 90 | 2 | PF02758 | |
| Domain | DAPIN | 4.98e-03 | 22 | 90 | 2 | IPR004020 | |
| Domain | PYRIN | 4.98e-03 | 22 | 90 | 2 | SM01289 | |
| Domain | Homeodomain-like | 5.38e-03 | 332 | 90 | 6 | IPR009057 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 5.26e-05 | 16 | 66 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 6.36e-05 | 17 | 66 | 3 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.23e-04 | 21 | 66 | 3 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.62e-04 | 23 | 66 | 3 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 2.36e-04 | 26 | 66 | 3 | M27483 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF462 CCNT1 BRIP1 MTA3 ZNF280D ATAD5 TMPO MLLT6 BCOR MGA PIAS2 EMSY ZNF292 | 1.34e-08 | 608 | 96 | 13 | 36089195 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 4.41e-07 | 444 | 96 | 10 | 34795231 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.24e-06 | 123 | 96 | 6 | 26912792 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.24e-06 | 283 | 96 | 8 | 30585729 | |
| Pubmed | 2.00e-06 | 74 | 96 | 5 | 29795351 | ||
| Pubmed | 2.48e-06 | 418 | 96 | 9 | 34709266 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.12e-06 | 430 | 96 | 9 | 35044719 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 5.10e-06 | 457 | 96 | 9 | 32344865 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 6.09e-06 | 351 | 96 | 8 | 38297188 | |
| Pubmed | Zrsr2 and functional U12-dependent spliceosome are necessary for follicular development. | 7.54e-06 | 2 | 96 | 2 | 35198906 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 33691379 | ||
| Pubmed | CASP8AP2 ANK3 ARHGAP31 ATF7IP KIAA1328 NCKAP5 MGA PIAS2 NUP153 | 8.35e-06 | 486 | 96 | 9 | 20936779 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | CCNT1 AFTPH ATAD5 UBAP2L PRRC2C ATF7IP TMPO TACC1 BCOR DHX29 EMSY NUP153 | 1.04e-05 | 934 | 96 | 12 | 33916271 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CCNT1 BRIP1 ATAD5 UBAP2L PRRC2C ATF7IP TMPO MLLT6 BCOR MGA EMSY NUP153 | 1.28e-05 | 954 | 96 | 12 | 36373674 |
| Pubmed | ZNF462 DRG2 ANK3 SBF1 UBAP2L PRRC2C ATF7IP BCOR MGA UNC79 EMSY NUP153 | 1.40e-05 | 963 | 96 | 12 | 28671696 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.61e-05 | 18 | 96 | 3 | 18834073 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 33530981 | ||
| Pubmed | Isolation and mapping of human homologues of an imprinted mouse gene U2af1-rs1. | 2.26e-05 | 3 | 96 | 2 | 8586425 | |
| Pubmed | Concurrent Zrsr2 mutation and Tet2 loss promote myelodysplastic neoplasm in mice. | 2.26e-05 | 3 | 96 | 2 | 36030305 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 10512748 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 2.60e-05 | 125 | 96 | 5 | 32891193 | |
| Pubmed | 3.63e-05 | 222 | 96 | 6 | 37071664 | ||
| Pubmed | The mammalian PYHIN gene family: phylogeny, evolution and expression. | 4.51e-05 | 4 | 96 | 2 | 22871040 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 9001233 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 23300874 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 32249212 | ||
| Pubmed | Association of IFI200 gene polymorphisms with susceptibility to systemic lupus erythematosus. | 4.51e-05 | 4 | 96 | 2 | 20595294 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 7558001 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 5.47e-05 | 146 | 96 | 5 | 23892456 | |
| Pubmed | 6.39e-05 | 359 | 96 | 7 | 35559673 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 14978255 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 14757431 | ||
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 1.02e-04 | 87 | 96 | 4 | 17148452 | |
| Pubmed | 1.03e-04 | 268 | 96 | 6 | 33640491 | ||
| Pubmed | 1.12e-04 | 529 | 96 | 8 | 14621295 | ||
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 19110483 | ||
| Pubmed | Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition. | 1.12e-04 | 6 | 96 | 2 | 33846634 | |
| Pubmed | Extensive evolutionary and functional diversity among mammalian AIM2-like receptors. | 1.12e-04 | 6 | 96 | 2 | 23045604 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.47e-04 | 180 | 96 | 5 | 35198878 | |
| Pubmed | 1.57e-04 | 7 | 96 | 2 | 9237760 | ||
| Pubmed | 1.60e-04 | 38 | 96 | 3 | 28680062 | ||
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 2.01e-04 | 41 | 96 | 3 | 20431927 | |
| Pubmed | 2.03e-04 | 104 | 96 | 4 | 10470851 | ||
| Pubmed | 2.09e-04 | 8 | 96 | 2 | 22190642 | ||
| Pubmed | 2.09e-04 | 8 | 96 | 2 | 32371981 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.29e-04 | 588 | 96 | 8 | 38580884 | |
| Pubmed | CCNT1 TNRC18 MTA3 PRRC2C TMPO MLLT6 BCOR IFI16 EMSY NUP153 ZNF292 | 2.34e-04 | 1103 | 96 | 11 | 34189442 | |
| Pubmed | 2.49e-04 | 44 | 96 | 3 | 27505670 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.50e-04 | 202 | 96 | 5 | 33005030 | |
| Pubmed | 2.67e-04 | 453 | 96 | 7 | 29656893 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.96e-04 | 774 | 96 | 9 | 15302935 | |
| Pubmed | 3.03e-04 | 47 | 96 | 3 | 29617656 | ||
| Pubmed | 3.08e-04 | 116 | 96 | 4 | 30804394 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 3.26e-04 | 332 | 96 | 6 | 32786267 | |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 3.26e-04 | 332 | 96 | 6 | 30595499 | |
| Pubmed | 3.34e-04 | 215 | 96 | 5 | 35973513 | ||
| Pubmed | 4.04e-04 | 808 | 96 | 9 | 20412781 | ||
| Pubmed | 4.08e-04 | 11 | 96 | 2 | 28842558 | ||
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 4.56e-04 | 54 | 96 | 3 | 25631074 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 4.79e-04 | 357 | 96 | 6 | 37059091 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZNF462 CCNT1 SLC5A6 GHITM CCSER2 TMEM209 TMPO SYVN1 IFI16 MGA PIAS2 | 4.87e-04 | 1203 | 96 | 11 | 29180619 |
| Pubmed | 4.89e-04 | 12 | 96 | 2 | 17632510 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 5.22e-04 | 363 | 96 | 6 | 14691545 | |
| Pubmed | ZNF462 MTA3 ATAD5 UBAP2L PRRC2C ATF7IP MLLT6 ZFHX3 BCOR MGA PIAS2 EMSY | 5.71e-04 | 1429 | 96 | 12 | 35140242 | |
| Pubmed | 5.72e-04 | 242 | 96 | 5 | 34011540 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 5.77e-04 | 13 | 96 | 2 | 31427429 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 6.19e-04 | 375 | 96 | 6 | 32788342 | |
| Pubmed | 6.71e-04 | 14 | 96 | 2 | 20854876 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 7.05e-04 | 697 | 96 | 8 | 28298427 | |
| Pubmed | FBXO3 Protein Promotes Ubiquitylation and Transcriptional Activity of AIRE (Autoimmune Regulator). | 7.73e-04 | 15 | 96 | 2 | 27365398 | |
| Pubmed | 7.86e-04 | 65 | 96 | 3 | 22496869 | ||
| Pubmed | CASP8AP2 DRG2 AFTPH ANK3 SBF1 ATAD5 GHITM CCSER2 TMEM209 TMPO TACC1 DHX29 | 8.08e-04 | 1487 | 96 | 12 | 33957083 | |
| Pubmed | 8.22e-04 | 396 | 96 | 6 | 26687479 | ||
| Pubmed | ANK3 UBAP2L DTL CCSER2 IFITM10 BCOR RNF122 MGA ANKRD40 NUP153 | 8.30e-04 | 1084 | 96 | 10 | 11544199 | |
| Pubmed | 8.31e-04 | 263 | 96 | 5 | 34702444 | ||
| Pubmed | 8.35e-04 | 549 | 96 | 7 | 38280479 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 8.43e-04 | 398 | 96 | 6 | 35016035 | |
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | 8.53e-04 | 152 | 96 | 4 | 28192407 | |
| Pubmed | 8.74e-04 | 153 | 96 | 4 | 10718198 | ||
| Pubmed | Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. | 8.82e-04 | 16 | 96 | 2 | 10391210 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 9.01e-04 | 724 | 96 | 8 | 36232890 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 9.83e-04 | 410 | 96 | 6 | 26949251 | |
| Pubmed | Comparative mapping of the imprinted U2afbpL gene on mouse chromosome 11 and human chromosome 5. | 9.98e-04 | 17 | 96 | 2 | 7956352 | |
| Pubmed | Novel cDNA clones obtained by antibody screening of a mouse cerebellar cDNA expression library. | 9.98e-04 | 17 | 96 | 2 | 7808216 | |
| Pubmed | 1.02e-03 | 568 | 96 | 7 | 37774976 | ||
| Pubmed | 1.12e-03 | 18 | 96 | 2 | 34171383 | ||
| Pubmed | 1.13e-03 | 282 | 96 | 5 | 23667531 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.21e-03 | 167 | 96 | 4 | 20362541 | |
| Pubmed | Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. | 1.25e-03 | 19 | 96 | 2 | 14578343 | |
| Pubmed | Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes. | 1.25e-03 | 19 | 96 | 2 | 20801936 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.26e-03 | 289 | 96 | 5 | 23752268 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.29e-03 | 170 | 96 | 4 | 23314748 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.41e-03 | 440 | 96 | 6 | 34244565 | |
| Pubmed | ETAA1 acts at stalled replication forks to maintain genome integrity. | 1.53e-03 | 21 | 96 | 2 | 27723720 | |
| Pubmed | 1.53e-03 | 21 | 96 | 2 | 19158679 | ||
| Pubmed | BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer | 1.53e-03 | 21 | 96 | 2 | 20301425 | |
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | 1.58e-03 | 450 | 96 | 6 | 16751776 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 1.65e-03 | 307 | 96 | 5 | 37499664 | |
| Pubmed | 1.95e-03 | 89 | 96 | 3 | 18950845 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 2.00e-03 | 321 | 96 | 5 | 32098917 | |
| Interaction | NUP43 interactions | ZNF462 CASP8AP2 BRIP1 ZNF280D PRRC2C ATF7IP CCSER2 MLLT6 ZFHX3 CCDC168 BCOR IFI16 MGA EMSY NUP153 ZNF292 | 2.52e-08 | 625 | 93 | 16 | int:NUP43 |
| Interaction | SOX5 interactions | 1.01e-05 | 162 | 93 | 7 | int:SOX5 | |
| Interaction | EGR2 interactions | 1.44e-05 | 171 | 93 | 7 | int:EGR2 | |
| Interaction | ASF1A interactions | 2.00e-05 | 249 | 93 | 8 | int:ASF1A | |
| Interaction | NUP35 interactions | ACOT9 PRRC2C TMEM216 MAMLD1 TMEM209 TMPO BCOR IFI16 NUP153 CRTC2 | 2.61e-05 | 424 | 93 | 10 | int:NUP35 |
| Interaction | CBX1 interactions | 5.62e-05 | 288 | 93 | 8 | int:CBX1 | |
| Interaction | TLE3 interactions | 6.02e-05 | 376 | 93 | 9 | int:TLE3 | |
| Interaction | POU5F1 interactions | ZNF462 MTA3 UBAP2L ACOT9 MUC16 TMPO TTI1 ZFHX3 MGA DHX29 EMSY | 7.82e-05 | 584 | 93 | 11 | int:POU5F1 |
| Interaction | KLF3 interactions | 8.98e-05 | 228 | 93 | 7 | int:KLF3 | |
| Interaction | H3C3 interactions | 9.52e-05 | 495 | 93 | 10 | int:H3C3 | |
| GeneFamily | CD molecules|Mucins | 7.18e-07 | 21 | 62 | 4 | 648 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 1.15e-04 | 5 | 62 | 2 | 995 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.18e-03 | 15 | 62 | 2 | 529 | |
| GeneFamily | Neuroblastoma breakpoint family | 2.79e-03 | 23 | 62 | 2 | 662 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 3.30e-03 | 25 | 62 | 2 | 994 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP | 7.92e-06 | 200 | 94 | 7 | M7256 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CDKN3 CASP8AP2 KIF18A HEG1 ZNF280D ATAD5 KIAA0586 TTI1 ZNF292 | 9.04e-06 | 311 | 93 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ATRIP ZNF280D ATAD5 UBAP2L KIAA0586 TMPO TTI1 ZFHX3 PIAS2 DHX29 ZNF292 | 3.58e-05 | 564 | 93 | 11 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CDKN3 CASP8AP2 KIF18A HEG1 AFTPH ATAD5 KIAA0586 CCSER2 MAMLD1 TTI1 NCKAP5 ANKRD40 ZNF292 | 6.62e-05 | 831 | 93 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CDKN3 CASP8AP2 KIF18A ABCA2 HEG1 AFTPH ZNF280D ATAD5 KIAA0586 MAMLD1 ZFHX2 TTI1 NCKAP5 ZNF292 | 9.88e-05 | 989 | 93 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ZNF462 CASP8AP2 KIF18A PLLP HEG1 ZNF280D ATAD5 KIAA0586 DTL KIAA1328 TMPO TTI1 ZFHX3 EMSY RAD54L ZNF292 | 1.05e-04 | 1257 | 93 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-07 | 180 | 95 | 7 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.79e-07 | 191 | 95 | 7 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.99e-07 | 194 | 95 | 7 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.06e-07 | 195 | 95 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-07 | 196 | 95 | 7 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 2.37e-07 | 199 | 95 | 7 | 6321140a1ebc1ff793fb6221a31e884368e42fa5 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.37e-07 | 199 | 95 | 7 | 88d130e2451e61afb710edf552e6b346b9fcfb2b | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.45e-07 | 200 | 95 | 7 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | Biopsy_IPF-Immune-Proliferating_Macrophages|Biopsy_IPF / Sample group, Lineage and Cell type | 2.45e-07 | 200 | 95 | 7 | 8abb2c25422717e994468ac02d8260344341467f | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.45e-07 | 200 | 95 | 7 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.66e-07 | 144 | 95 | 6 | 3ba7f8bd6d1c551048403c94693d63e60f7cbbb7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-06 | 169 | 95 | 6 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-06 | 169 | 95 | 6 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-06 | 174 | 95 | 6 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-06 | 175 | 95 | 6 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-06 | 175 | 95 | 6 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 179 | 95 | 6 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 2.60e-06 | 182 | 95 | 6 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-06 | 185 | 95 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.95e-06 | 186 | 95 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-06 | 187 | 95 | 6 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-06 | 187 | 95 | 6 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-06 | 187 | 95 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-06 | 188 | 95 | 6 | 319fbeca200ab998daf49fcaee0bfdb57bf7ee4b | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 3.14e-06 | 188 | 95 | 6 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-06 | 189 | 95 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 3.33e-06 | 190 | 95 | 6 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.33e-06 | 190 | 95 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.65e-06 | 193 | 95 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.76e-06 | 194 | 95 | 6 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-06 | 194 | 95 | 6 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.76e-06 | 194 | 95 | 6 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.76e-06 | 194 | 95 | 6 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.76e-06 | 194 | 95 | 6 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.76e-06 | 194 | 95 | 6 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-06 | 195 | 95 | 6 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.87e-06 | 195 | 95 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.99e-06 | 196 | 95 | 6 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.99e-06 | 196 | 95 | 6 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.99e-06 | 196 | 95 | 6 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.99e-06 | 196 | 95 | 6 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 3.99e-06 | 196 | 95 | 6 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.11e-06 | 197 | 95 | 6 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 197 | 95 | 6 | 7eb4c1cffd0366204af7e63adc8f751685601a94 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.11e-06 | 197 | 95 | 6 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 4.23e-06 | 198 | 95 | 6 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.23e-06 | 198 | 95 | 6 | 6a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 4.23e-06 | 198 | 95 | 6 | c65cdb54409087014125a76627e5efb5fe8dabc9 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.23e-06 | 198 | 95 | 6 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.23e-06 | 198 | 95 | 6 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.23e-06 | 198 | 95 | 6 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.23e-06 | 198 | 95 | 6 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.35e-06 | 199 | 95 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 4.35e-06 | 199 | 95 | 6 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 4.35e-06 | 199 | 95 | 6 | 4142d5b1b20212508f95841fdac4efb7655616cb | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | 4.35e-06 | 199 | 95 | 6 | e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.35e-06 | 199 | 95 | 6 | 446cd7d960812519fe2b8e434578ef0b668c75ce | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 4.35e-06 | 199 | 95 | 6 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.35e-06 | 199 | 95 | 6 | e3b69608c834bd8ce6bedde298a2763cc0d7d573 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.35e-06 | 199 | 95 | 6 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-06 | 200 | 95 | 6 | 2938a029fa0478be561574ace91f95c4a528b2d4 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 4.48e-06 | 200 | 95 | 6 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.48e-06 | 200 | 95 | 6 | 535f6fba8d03873ba35c9949579161dc41cd7a60 | |
| ToppCell | Severe_COVID-19-T/NK-proliferating_T/NK|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.48e-06 | 200 | 95 | 6 | 52265e761a961f3724b388285e0919bd58847138 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-06 | 200 | 95 | 6 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | medial-Hematologic-Proliferating_NK/T-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.48e-06 | 200 | 95 | 6 | ab1f9f99cb4a381a642a2cfb32e7f8d276c2dda4 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 4.48e-06 | 200 | 95 | 6 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors_nGenesUnder4k|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-06 | 200 | 95 | 6 | 8223d2c9b9e05b1d26e3de1bc0226d175af2e7b2 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.48e-06 | 200 | 95 | 6 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-06 | 200 | 95 | 6 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.48e-06 | 200 | 95 | 6 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | LAM-Myeloid-pMacrophage|Myeloid / Condition, Lineage and Cell class | 4.48e-06 | 200 | 95 | 6 | 0078d56337d44074326e8ccd1d412d098d86eeab | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.48e-06 | 200 | 95 | 6 | 3c3ac587ad98e3f6be809eac18c7742a23140de1 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-T/NK_proliferative|Int-URO / Disease, condition lineage and cell class | 4.48e-06 | 200 | 95 | 6 | 99acc1ea01288efdd5b166aa20d66735f2bbe543 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-06 | 200 | 95 | 6 | cfe017b4a4d604a553d0a3df9659687f38e9a7af | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.48e-06 | 200 | 95 | 6 | 5c84aaedac9f27da0da0493dab7c8f7a4d66888c | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.48e-06 | 200 | 95 | 6 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.48e-06 | 200 | 95 | 6 | 60d11275f06490f86f400a2802492f9c1b570400 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 4.48e-06 | 200 | 95 | 6 | 381bafdde6492f020ae93ab8fffa6215c631c570 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-06 | 200 | 95 | 6 | cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.48e-06 | 200 | 95 | 6 | 2afbb5b5742b956993796621fea7e0c9888754a1 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.48e-06 | 200 | 95 | 6 | 5d11a2c0021805e78d97dc1638bf73ca1faede66 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.48e-06 | 200 | 95 | 6 | 43571c9284d4e41402a2d1eefc1efe2ce8476d4a | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 4.48e-06 | 200 | 95 | 6 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.48e-06 | 200 | 95 | 6 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.48e-06 | 200 | 95 | 6 | dd7ad295ab3ba4c19babffb1625900db414bb5a9 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.48e-06 | 200 | 95 | 6 | 4462ebd5d4632788f10a93fadd2babae701c754f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.48e-06 | 200 | 95 | 6 | e269a61858ac610e914b684d9a3c084e9600fb1c | |
| ToppCell | Biopsy_IPF-Immune-Proliferating_T_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 4.48e-06 | 200 | 95 | 6 | c43d1a83b2a8ad060f3d80c9438da8b7a5e307fb | |
| ToppCell | medial-Hematologic-Proliferating_NK/T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.48e-06 | 200 | 95 | 6 | bfde42e00a9a6b858937de87cd19c9ed3677d954 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.48e-06 | 200 | 95 | 6 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_T_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.48e-06 | 200 | 95 | 6 | dd374e153106fff8a22483ba7f63b3fa3d3ab2ea | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.48e-06 | 200 | 95 | 6 | 0e44a55d65b72eb40543d3bde301f8598ac251c3 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.48e-06 | 200 | 95 | 6 | 6145bdee0d9954da7b096be4fe797066a6df2bd0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells-Neuroepithelial_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-06 | 200 | 95 | 6 | 55501f83409e0174c756a13ad8077f5b59975e27 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-06 | 200 | 95 | 6 | b9aad527d3ad5bc701e93fa2afdebf695b2a74bb | |
| ToppCell | medial-2-Hematologic-Proliferating_NK/T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.48e-06 | 200 | 95 | 6 | 3d1895490dd262e9246eb280938239a7253451dd | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-06 | 200 | 95 | 6 | 8f9e76048ae6f45218a09a95a2c4b31e8a8937b2 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.48e-06 | 200 | 95 | 6 | f95769e24763900eac317c6f8adbf064bae9feaf | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-05 | 144 | 95 | 5 | 38ff324366ad5be626e3657c1e33277fc36ddd4c | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 9.35e-05 | 5 | 91 | 2 | DOID:3030 (is_marker_for) | |
| Disease | Disorder of eye | 5.15e-04 | 212 | 91 | 5 | C0015397 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 6.08e-04 | 12 | 91 | 2 | C0023485 | |
| Disease | triacylglycerol 56:9 measurement | 1.24e-03 | 17 | 91 | 2 | EFO_0010436 | |
| Disease | Feeding difficulties | 1.39e-03 | 18 | 91 | 2 | C0232466 | |
| Disease | pentachlorophenol measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022056 | |
| Disease | diazinon measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0022058 | |
| Disease | environmental exposure measurement | 1.51e-03 | 73 | 91 | 3 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 1.57e-03 | 74 | 91 | 3 | EFO_0007886 | |
| Disease | BREAST CANCER | 1.90e-03 | 21 | 91 | 2 | 114480 | |
| Disease | response to mTOR inhibitor | 2.69e-03 | 25 | 91 | 2 | EFO_0005417 | |
| Disease | systemic mastocytosis | 2.69e-03 | 25 | 91 | 2 | MONDO_0016586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MDPFKPTTTLTSSDF | 426 | O75410 | |
| LPSVKSPSVTSSQAM | 206 | Q6N043 | |
| PVILTTSDPTFSLMF | 1331 | Q96QE3 | |
| SLSSMSPISSLPALF | 666 | P55198 | |
| SNTSLLATSSPMPVK | 246 | P47902 | |
| MPSPTFLTQVKESLS | 31 | P02655 | |
| STLPSLFMTSTASPV | 256 | Q6QNK2 | |
| LTSFSILMSPFVPST | 566 | Q5T601 | |
| KVLMFPATLTPSTSS | 916 | Q6ULP2 | |
| IAFSSTSLLKMAPSA | 241 | Q9Y305 | |
| SRSLFSSVPSKPPMS | 216 | Q6AI12 | |
| KSSSLNFSFPSLPTM | 596 | O60563 | |
| VSSVSPKPPSSFKMS | 486 | Q9NZJ0 | |
| LAAVMTEKSPFTTPI | 1101 | Q7Z478 | |
| TSPSVALSKPYMTVS | 366 | Q6W2J9 | |
| VFSGSPPMKSLSSTS | 1286 | Q6W2J9 | |
| LSFLKPDMSSSSTPE | 1456 | Q9UKL3 | |
| MLLSPVTSTPFSVKD | 1 | A6NCS4 | |
| SPSSPDFVFMLSSKA | 561 | Q92698 | |
| MAEFPSKVSTRTSSP | 1 | Q9Y342 | |
| PVKITSPMKTFADST | 186 | Q8WXI7 | |
| PTPKVTMSSTFSTQR | 1161 | Q8WXI7 | |
| TTSPTKSPTENMLAT | 3266 | Q8WXI7 | |
| KTSSPSSFLSSPAMT | 5036 | Q8WXI7 | |
| SSFLSSPAMTTPSLI | 5041 | Q8WXI7 | |
| IEKTSFSSSLMPSPA | 6796 | Q8WXI7 | |
| LSLSAMISPSPVSST | 7396 | Q8WXI7 | |
| EKTRPSFSLMSSPAT | 7966 | Q8WXI7 | |
| SSFSVTSLLTPGMVK | 10046 | Q8WXI7 | |
| MTATSFKTTTTYPTP | 1591 | Q6W4X9 | |
| LSSPLSSMKSSISSP | 261 | P08235 | |
| SPLQIPMTSSFSSTL | 406 | O60732 | |
| SSFPSIKATRIPAIM | 1271 | Q5T1H1 | |
| SAMLVSTAASPSLIK | 301 | P42166 | |
| PTTLKGMFDSTPTFL | 246 | O60721 | |
| SIPSSITSILSMFPT | 2306 | Q2M2H8 | |
| PRTLLPSTSNSKMAS | 1491 | Q8IWI9 | |
| FVSSLGSMFLPPTTV | 256 | Q9H3K2 | |
| NPSTVTLMKPSSFTT | 716 | Q8NI77 | |
| SKVSATDMSTIPPSA | 3031 | Q2LD37 | |
| SSSPSKEFMTLTLSR | 651 | A0A1B0GTH6 | |
| MPSTSPKPSTTNVFT | 241 | A1E959 | |
| MYSSSSCKLPSLSPV | 31 | Q92764 | |
| TFTTTILKTSQPLMT | 841 | Q9ULI3 | |
| TNSSFTSFLTISPKM | 181 | Q6ZSS7 | |
| PTLCEMLSYTPSSSK | 306 | P34949 | |
| STSPFAMSKSSLRPP | 31 | Q4G0G2 | |
| ASTSPMPTGSLKDFV | 481 | Q86T90 | |
| FPPPTTSTSSLKMQD | 351 | O95248 | |
| VLTSGTLSPMKSFSS | 611 | Q9BX63 | |
| SVSLFTSKLAKPSTM | 116 | Q9H7U1 | |
| LASMPSSVPKTSVES | 171 | A6NFR6 | |
| LPKQFSPTMSPTLSS | 451 | Q53ET0 | |
| PSQSIFFSPVSISMS | 61 | P05154 | |
| MPPTTPSSSSFTKKD | 441 | Q6K0P9 | |
| PTLFPMESKSSKTDS | 101 | A6NMD0 | |
| TTTMSILTGLFPPTS | 1031 | Q9BZC7 | |
| TMSSPIKTVVSQSPY | 1576 | Q12955 | |
| PIQMKIPISAFSTSS | 906 | Q6VMQ6 | |
| TLSTTPKPSVQMSHL | 216 | Q13495 | |
| MPPTTPSSSFFTKKS | 431 | Q16666 | |
| QMPPSTPSSSFLTTK | 486 | Q16666 | |
| PVPASSSTKLLMTSY | 26 | Q6UXX5 | |
| MSPVKITFTKPSTQT | 256 | Q7Z589 | |
| SFPTKESFSANMSLP | 246 | Q8WXE1 | |
| IFGSCMPALSTPKTT | 1676 | Q8NDH2 | |
| MKPTTSPSSLTTLLR | 2041 | A6NE01 | |
| MKPPSSIQTSEFDSS | 1 | Q16667 | |
| LSLMSTVPPTRSFTS | 11 | A0A096LNP1 | |
| PMFLDSLTSPLTASS | 566 | O75928 | |
| FSSDPLTTPLLMLTT | 56 | P03905 | |
| SISSTMAFVSTAPLP | 156 | Q685J3 | |
| STPLTSMPVSKTLLT | 746 | Q685J3 | |
| MSPTPVFTTLKTAVT | 241 | Q9H195 | |
| STALSKIMSTSQFPI | 531 | Q9H195 | |
| KIMSTSQFPIPSTHS | 536 | Q9H195 | |
| STIPLTMKPSSSLPT | 801 | Q9H195 | |
| TMKPSSSLPTILRTS | 806 | Q9H195 | |
| SRISPPVSTSMKDSS | 26 | Q6ZUA9 | |
| TPSLQTPTTKRMLTT | 551 | Q9BTC8 | |
| SKPVAISVASYSPMS | 796 | Q9P2F6 | |
| SITSMRPFTATTKPE | 411 | Q9NSD7 | |
| PTVVYLTKSSPSMAV | 31 | Q86TM6 | |
| FSSPPSPKLMASFTL | 136 | O75445 | |
| ISGLSSTSKLSLPMF | 106 | Q76EJ3 | |
| LNKTTPSEMPSTAST | 61 | Q96KW9 | |
| SSSFTVMALGPPKVS | 1026 | O14513 | |
| STLSIPPEMLASYKS | 226 | Q5TI25 | |
| STLSIPPEMLASYKS | 226 | B4DH59 | |
| VATVTTLMPLTTFSK | 501 | Q9Y289 | |
| TLMPLTTFSKPTGLQ | 506 | Q9Y289 | |
| TFLPTTCSSEMPLSS | 786 | Q5QGS0 | |
| LTSVPPTTFSLTFKM | 2236 | Q9Y520 | |
| PSVGKSTFLSLMTST | 71 | P55039 | |
| SLTSSTKSSPTPMTL | 366 | P23515 | |
| PASTSMTPASITAAK | 126 | Q9UGN4 | |
| PSSSKLTPSLLCSMV | 1751 | O15417 | |
| SPFTKRQAFTPSSTM | 416 | Q14157 | |
| MTFTTKVLSAPTLSP | 1051 | Q9C0A1 | |
| LVSTNKSCSMPPISF | 16 | Q9H9V4 | |
| MFTSKSNSVSPSPSL | 1 | A6NEE1 | |
| PFSSFISVMPTKSNI | 1811 | O60281 | |
| PSKSVFTSSLFQMEP | 461 | Q2M1Z3 | |
| PTTFYTSLPTKSLNM | 6 | M5A8F1 | |
| TEAPTTMTYPLKATS | 241 | Q9Y279 | |
| GSPMFKFSSPIVKST | 521 | P49790 | |
| SFFASKPSPTAMILN | 791 | Q6ZN44 | |
| RSPSTSPKFTTSCMT | 146 | Q96SK2 | |
| KSAPSPTSNSTYLTM | 291 | Q96JM2 | |
| SSPTLLIKSMFTTFG | 201 | Q15695 | |
| KMPLSISVALTFPSA | 86 | Q9P0N5 | |
| SSPTLLIKSMFTTFG | 196 | Q15696 | |
| ALKTSSFQPVSMPSS | 261 | Q9BVV6 | |
| SFLAFSKPSPTICSM | 606 | O43156 | |
| ATSPSTPTSTMNTLK | 2601 | Q15911 | |
| KSSLLSAPSIVSMFV | 1976 | Q9P2D8 |